Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1993 Jan 9;306(6870):115–119. doi: 10.1136/bmj.306.6870.115

Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria.

PMCID: PMC1676688  PMID: 8435608

Abstract

Efficient neonatal screening for phenylketonuria and the availability of complex diets for lifelong use have virtually eliminated severe mental handicap from the disease. Nevertheless, there remains a high risk of fetal damage in offspring of women with the disease, and the possibility that the diets themselves may be harmful cannot be excluded. Search for a preventive treatment for the disease has been greatly aided by advances in molecular genetics. For example, in mice modified liver cells have been implanted, which have not only corrected the phenylalanine defect but have remained healthy for the normal life span of the animal. Overall, however, prevention and treatment have not progressed as quickly as was hoped, and research and development must be pursued vigorously to take account of contemporary perceptions of the disorder.

Full text

PDF
115

Images in this article

117p117-a
on p.117
117p117-b
on p.117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berry H. K., Brunner R. L., Hunt M. M., White P. P. Valine, isoleucine, and leucine. A new treatment for phenylketonuria. Am J Dis Child. 1990 May;144(5):539–543. doi: 10.1001/archpedi.1990.02150290033020. [DOI] [PubMed] [Google Scholar]
  2. Binek-Singer P., Johnson T. C. The effects of chronic hyperphenylalaninaemia on mouse brain protein synthesis can be prevented by other amino acids. Biochem J. 1982 Aug 15;206(2):407–414. doi: 10.1042/bj2060407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brunner R. L., Jordan M. K., Berry H. K. Early-treated phenylketonuria: neuropsychologic consequences. J Pediatr. 1983 Jun;102(6):831–835. doi: 10.1016/s0022-3476(83)80007-9. [DOI] [PubMed] [Google Scholar]
  4. Cabalska B., Duczyńska N., Borzymowska J., Zorska K., Koślacz-Folga A., Bozkowa K. Termination of dietary treatment in phenylketonuria. Eur J Pediatr. 1977 Nov 4;126(4):253–262. doi: 10.1007/BF00477051. [DOI] [PubMed] [Google Scholar]
  5. Dobson J. C., Williamson M. L., Azen C., Koch R. Intellectual assessment of 111 four-year-old children with phenylketonuria. Pediatrics. 1977 Dec;60(6):822–827. [PubMed] [Google Scholar]
  6. Drogari E., Smith I., Beasley M., Lloyd J. K. Timing of strict diet in relation to fetal damage in maternal phenylketonuria. An international collaborative study by the MRC/DHSS Phenylketonuria Register. Lancet. 1987 Oct 24;2(8565):927–930. doi: 10.1016/s0140-6736(87)91418-8. [DOI] [PubMed] [Google Scholar]
  7. Fishler K., Azen C. G., Henderson R., Friedman E. G., Koch R. Psychoeducational findings among children treated for phenylketonuria. Am J Ment Defic. 1987 Jul;92(1):65–73. [PubMed] [Google Scholar]
  8. Holtzman N. A., Kronmal R. A., van Doorninck W., Azen C., Koch R. Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria. N Engl J Med. 1986 Mar 6;314(10):593–598. doi: 10.1056/NEJM198603063141001. [DOI] [PubMed] [Google Scholar]
  9. Hommes F. A., Eller A. G., Taylor E. H. Turnover of the fast components of myelin and myelin proteins in experimental hyperphenylalaninaemia. Relevance to termination of dietary treatment in human phenylketonuria. J Inherit Metab Dis. 1982;5(1):21–27. doi: 10.1007/BF01799750. [DOI] [PubMed] [Google Scholar]
  10. Hoskins J. A., Jack G., Wade H. E., Peiris R. J., Wright E. C., Starr D. J., Stern J. Enzymatic control of phenylalanine intake in phenylketonuria. Lancet. 1980 Feb 23;1(8165):392–394. doi: 10.1016/s0140-6736(80)90944-7. [DOI] [PubMed] [Google Scholar]
  11. Jaruzelska J., Henriksen K. F., Güttler F., Riess O., Borski K., Blin N., Slomski R. The codon 408 mutation associated with haplotype 2 is predominant in Polish families with phenylketonuria. Hum Genet. 1991 Jan;86(3):247–250. doi: 10.1007/BF00202402. [DOI] [PubMed] [Google Scholar]
  12. Kaufman S. An evaluation of the possible neurotoxicity of metabolites of phenylalanine. J Pediatr. 1989 May;114(5):895–900. doi: 10.1016/s0022-3476(89)80161-1. [DOI] [PubMed] [Google Scholar]
  13. Koch R., Azen C. G., Friedman E. G., Williamson M. L. Preliminary report on the effects of diet discontinuation in PKU. J Pediatr. 1982 Jun;100(6):870–875. doi: 10.1016/s0022-3476(82)80503-9. [DOI] [PubMed] [Google Scholar]
  14. Koch R., Azen C., Friedman E. G., Williamson M. L. Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age. J Inherit Metab Dis. 1984;7(2):86–90. doi: 10.1007/BF01805813. [DOI] [PubMed] [Google Scholar]
  15. Konecki D. S., Lichter-Konecki U. The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations. Hum Genet. 1991 Aug;87(4):377–388. doi: 10.1007/BF00197152. [DOI] [PubMed] [Google Scholar]
  16. Krause W., Halminski M., McDonald L., Dembure P., Salvo R., Freides D., Elsas L. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man. J Clin Invest. 1985 Jan;75(1):40–48. doi: 10.1172/JCI111695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lenke R. R., Levy H. L. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med. 1980 Nov 20;303(21):1202–1208. doi: 10.1056/NEJM198011203032104. [DOI] [PubMed] [Google Scholar]
  18. Levy H. L., Waisbren S. E. Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus. N Engl J Med. 1983 Nov 24;309(21):1269–1274. doi: 10.1056/NEJM198311243092101. [DOI] [PubMed] [Google Scholar]
  19. Lou H. C., Lykkelund C., Gerdes A. M., Udesen H., Bruhn P. Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatr Scand. 1987 Jul;76(4):560–565. doi: 10.1111/j.1651-2227.1987.tb10521.x. [DOI] [PubMed] [Google Scholar]
  20. Malamud N. Neuropathology of phenylketonuria. J Neuropathol Exp Neurol. 1966 Apr;25(2):254–268. doi: 10.1097/00005072-196604000-00006. [DOI] [PubMed] [Google Scholar]
  21. McKean C. M., Boggs D. E., Peterson N. A. The influence of high phenylalanine and tyrosine on the concentrations of essential amino acids in brain. J Neurochem. 1968 Mar;15(3):235–241. doi: 10.1111/j.1471-4159.1968.tb06202.x. [DOI] [PubMed] [Google Scholar]
  22. Melnick C. R., Michals K. K., Matalon R. Linguistic development of children with phenylketonuria and normal intelligence. J Pediatr. 1981 Feb;98(2):269–272. doi: 10.1016/s0022-3476(81)80658-0. [DOI] [PubMed] [Google Scholar]
  23. Okano Y., Eisensmith R. C., Güttler F., Lichter-Konecki U., Konecki D. S., Trefz F. K., Dasovich M., Wang T., Henriksen K., Lou H. Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med. 1991 May 2;324(18):1232–1238. doi: 10.1056/NEJM199105023241802. [DOI] [PubMed] [Google Scholar]
  24. Pennington B. F., van Doorninck W. J., McCabe L. L., McCabe E. R. Neuropsychological deficits in early treated phenylketonuric children. Am J Ment Defic. 1985 Mar;89(5):467–474. [PubMed] [Google Scholar]
  25. Smith I., Beasley M. G., Ades A. E. Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child. 1990 May;65(5):472–478. doi: 10.1136/adc.65.5.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Smith I., Beasley M. G., Wolff O. H., Ades A. E. Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register. J Pediatr. 1988 Mar;112(3):403–408. doi: 10.1016/s0022-3476(88)80320-2. [DOI] [PubMed] [Google Scholar]
  27. Smith I., Cook B., Beasley M. Review of neonatal screening programme for phenylketonuria. BMJ. 1991 Aug 10;303(6798):333–335. doi: 10.1136/bmj.303.6798.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Smith I., Glossop J., Beasley M. Fetal damage due to maternal phenylketonuria: effects of dietary treatment and maternal phenylalanine concentrations around the time of conception (an interim report from the UK Phenylketonuria Register). J Inherit Metab Dis. 1990;13(4):651–657. doi: 10.1007/BF01799520. [DOI] [PubMed] [Google Scholar]
  29. Smith I., Lobascher M. E., Stevenson J. E., Wolff O. H., Schmidt H., Grubel-Kaiser S., Bickel H. Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria. Br Med J. 1978 Sep 9;2(6139):723–726. doi: 10.1136/bmj.2.6139.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Thompson A. J., Smith I., Brenton D., Youl B. D., Rylance G., Davidson D. C., Kendall B., Lees A. J. Neurological deterioration in young adults with phenylketonuria. Lancet. 1990 Sep 8;336(8715):602–605. doi: 10.1016/0140-6736(90)93401-a. [DOI] [PubMed] [Google Scholar]
  31. Thompson A. J., Smith I., Kendall B. E., Youl B. D., Brenton D. Magnetic resonance imaging changes in early treated patients with phenylketonuria. Lancet. 1991 May 18;337(8751):1224–1224. doi: 10.1016/0140-6736(91)92894-8. [DOI] [PubMed] [Google Scholar]
  32. Villasana D., Butler I. J., Williams J. C., Roongta S. M. Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis. 1989;12(4):451–457. doi: 10.1007/BF01802042. [DOI] [PubMed] [Google Scholar]
  33. Waisbren S. E., Schnell R., Levy H. L. Intelligence and personality characteristics in adults with untreated atypical phenylketonuria and mild hyperphenylalaninemia. J Pediatr. 1984 Dec;105(6):955–958. doi: 10.1016/s0022-3476(84)80088-8. [DOI] [PubMed] [Google Scholar]
  34. Welsh M. C., Pennington B. F., Ozonoff S., Rouse B., McCabe E. R. Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev. 1990 Dec;61(6):1697–1713. [PubMed] [Google Scholar]
  35. Woo S. L. Molecular basis and population genetics of phenylketonuria. Biochemistry. 1989 Jan 10;28(1):1–7. doi: 10.1021/bi00427a001. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES